Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations
出版年份 2020 全文链接
标题
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 2, Pages 489
出版商
MDPI AG
发表日期
2020-01-13
DOI
10.3390/ijms21020489
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease
- (2020) Susanne Seemann et al. BIOCHEMICAL JOURNAL
- Clinical trials in amyotrophic lateral sclerosis
- (2019) Christopher J. McDermott CURRENT OPINION IN NEUROLOGY
- β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
- (2019) Maria Monticelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohort
- (2019) Albina Nowak et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Functional rescue of misfolding ABCA3 mutations by small molecular correctors
- (2018) Susanna Kinting et al. HUMAN MOLECULAR GENETICS
- Probing the Inhibitor versus Chaperone Properties of sp2-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease
- (2018) Teresa Mena-Barragán et al. MOLECULES
- UniProt: the universal protein knowledgebase
- (2018) The UniProt Consortium NUCLEIC ACIDS RESEARCH
- Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases
- (2018) Ya-Xiong Tao et al. PHYSIOLOGICAL REVIEWS
- Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
- (2018) David M. Pereira et al. Chemical Science
- Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders
- (2018) Zhi-Shuai Hou et al. Expert Review of Clinical Pharmacology
- Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria
- (2018) Pedro Urquiza et al. Science Translational Medicine
- In silico and in vivo models for Qatari-specific classical homocystinuria as basis for development of novel therapies
- (2018) Hesham M. Ismail et al. HUMAN MUTATION
- FDA approves Galafold, a triumph for Amicus
- (2018) Nuala Moran NATURE BIOTECHNOLOGY
- The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase
- (2018) Cathrine K. Fog et al. EBioMedicine
- Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family With Familial Isolated Hypoparathyroidism
- (2017) Luigia Cinque et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Screening methods for identifying pharmacological chaperones
- (2017) Min Hyeon Shin et al. Molecular BioSystems
- In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
- (2017) Jan Lukas et al. Jove-Journal of Visualized Experiments
- Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases
- (2016) Marino Convertino et al. ACS Chemical Biology
- Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases
- (2016) Elena M. Sánchez-Fernández et al. CHEMICAL COMMUNICATIONS
- The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat
- (2016) Elfrida R. Benjamin et al. GENETICS IN MEDICINE
- Small molecules as therapeutic agents for inborn errors of metabolism
- (2016) Leslie Matalonga et al. JOURNAL OF INHERITED METABOLIC DISEASE
- MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search
- (2016) Noa Rappaport et al. NUCLEIC ACIDS RESEARCH
- Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease
- (2016) Valentina Citro et al. PLoS One
- In vivo aspects of protein folding and quality control
- (2016) D. Balchin et al. SCIENCE
- Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria
- (2016) Antje Banning et al. Scientific Reports
- pH-Responsive Pharmacological Chaperones for Rescuing Mutant Glycosidases
- (2015) Teresa Mena-Barragán et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Looking for protein stabilizing drugs with thermal shift assay
- (2015) Giuseppina Andreotti et al. Drug Testing and Analysis
- Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model
- (2015) Nupur Dasgupta et al. HUMAN MOLECULAR GENETICS
- 4-Phenylbutyrate protects rat skin flaps against ischemia-reperfusion injury and apoptosis by inhibiting endoplasmic reticulum stress
- (2015) ZHEN-SHUANG YUE et al. Molecular Medicine Reports
- Enzyme Enhancers for the Treatment of Fabry and Pompe Disease
- (2015) Jan Lukas et al. MOLECULAR THERAPY
- Drug repositioning can accelerate discovery of pharmacological chaperones
- (2015) Bruno Hay Mele et al. Orphanet Journal of Rare Diseases
- Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
- (2015) Giuseppina Andreotti et al. PLoS One
- Molecular Basis of 1-Deoxygalactonojirimycin Arylthiourea Binding to Human α-Galactosidase A: Pharmacological Chaperoning Efficacy on Fabry Disease Mutants
- (2014) Yi Yu et al. ACS Chemical Biology
- Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics
- (2014) Ya-Xiong Tao et al. ENDOCRINE REVIEWS
- Conformational Response to Ligand Binding in Phosphomannomutase2
- (2014) Giuseppina Andreotti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa
- (2014) D A Parfitt et al. Cell Death & Disease
- A thermodynamic assay to test pharmacological chaperones for Fabry disease
- (2013) Giuseppina Andreotti et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- 4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor
- (2013) Seisuke Mimori et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Impact of Clinically Relevant Mutations on the Pharmacoregulation and Signaling Bias of the Calcium-Sensing Receptor by Positive and Negative Allosteric Modulators
- (2013) Katie Leach et al. ENDOCRINOLOGY
- Loss-of-Function and Gain-of-Function Mutations of Calcium-Sensing Receptor: Functional Analysis and the Effect of Allosteric Modulators NPS R-568 and NPS 2143
- (2013) Akie Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
- (2013) Robert E. Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase 2 study of migalastat hydrochloride in females with Fabry disease: Selection of population, safety and pharmacodynamic effects
- (2013) R. Giugliani et al. MOLECULAR GENETICS AND METABOLISM
- Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
- (2013) Marco Cammisa et al. Orphanet Journal of Rare Diseases
- Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
- (2013) Jan Lukas et al. PLoS Genetics
- Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation
- (2013) Giuseppina Andreotti et al. Molecular Genetics & Genomic Medicine
- Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate
- (2012) Brie Sorrenson et al. JOURNAL OF LIPID RESEARCH
- Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders
- (2012) Zacharoula Konsoula et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- The Molecular Basis of Pharmacological Chaperoning in Human α-Galactosidase
- (2011) Abigail I. Guce et al. CHEMISTRY & BIOLOGY
- Pharmacological chaperone therapy for Gaucher disease: a patent review
- (2011) Juan M Benito et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A pharmacogenetic approach to identify mutant forms of α-galactosidase a that respond to a pharmacological chaperone for Fabry disease
- (2011) Xiaoyang Wu et al. HUMAN MUTATION
- 4-Phenylbutyrate Stimulates Hsp70 Expression through the Elp2 Component of Elongator and STAT-3 in Cystic Fibrosis Epithelial Cells
- (2011) Laurence Suaud et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ex Vivoandin VivoEffects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
- (2011) Ying Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular mechanism for stabilization of a mutant α-galactosidase A involving M51I amino acid substitution by imino sugars
- (2011) Takahiro Tsukimura et al. MOLECULAR GENETICS AND METABOLISM
- Looking-Glass Synergistic Pharmacological Chaperones: DGJ and L-DGJ from the Enantiomers of Tagatose
- (2011) Sarah F. Jenkinson et al. ORGANIC LETTERS
- Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests
- (2011) Giuseppina Andreotti et al. Orphanet Journal of Rare Diseases
- Expression and In Vivo Rescue of Human ABCC6 Disease-Causing Mutants in Mouse Liver
- (2011) Olivier Le Saux et al. PLoS One
- Quantitative Correlation of Physical and Chemical Properties with Chemical Structure: Utility for Prediction
- (2010) Alan R. Katritzky et al. CHEMICAL REVIEWS
- The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
- (2010) Richie Khanna et al. FEBS Journal
- Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability
- (2009) Raquel L. Lieberman et al. BIOCHEMISTRY
- Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
- (2009) Giancarlo Parenti EMBO Molecular Medicine
- Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin
- (2009) Peter V. E. van den Berghe et al. HEPATOLOGY
- The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase
- (2009) John J. Flanagan et al. HUMAN MUTATION
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The pharmacological chaperone 1-deoxygalactonojirimycin increases α-galactosidase A levels in Fabry patient cell lines
- (2009) E. R. Benjamin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
- (2008) Ting-Wei Mu et al. CELL
- Structural characterization of mutant α-galactosidases causing Fabry disease
- (2008) Kanako Sugawara et al. JOURNAL OF HUMAN GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More